These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 11510996

  • 21. Effects of trypanocidal drugs on protein biosynthesis in vitro and in vivo by Trypanosoma cruzi.
    Gonzalez NS, Cazzulo JJ.
    Biochem Pharmacol; 1989 Sep 01; 38(17):2873-7. PubMed ID: 2673249
    [Abstract] [Full Text] [Related]

  • 22. Quinoxaline N,N'-dioxide derivatives and related compounds as growth inhibitors of Trypanosoma cruzi. Structure-activity relationships.
    Aguirre G, Cerecetto H, Di Maio R, González M, Alfaro ME, Jaso A, Zarranz B, Ortega MA, Aldana I, Monge-Vega A.
    Bioorg Med Chem Lett; 2004 Jul 16; 14(14):3835-9. PubMed ID: 15203172
    [Abstract] [Full Text] [Related]

  • 23. Isoxazolylnaphthoquinone effects on the growth of Trypanosoma cruzi.
    Amuchástegui PI, Moretti ER, Basso B, Sperandeo N, de Bertorello MM.
    Rev Argent Microbiol; 1990 Jul 16; 22(4):199-207. PubMed ID: 2129475
    [Abstract] [Full Text] [Related]

  • 24. [Effects of nifurtimox, benznidazole, and beta-lapachone on the metabolism of DNA, RNA and proteins in Trypanosoma cruzi].
    Goijman SG, Stoppani AO.
    Rev Argent Microbiol; 1983 Jul 16; 15(4):193-204. PubMed ID: 6086046
    [Abstract] [Full Text] [Related]

  • 25. Biological characterization of Trypanosoma cruzi strains.
    Martínez-Díaz RA, Escario JA, Nogal-Ruiz JJ, Gómez-Barrio A.
    Mem Inst Oswaldo Cruz; 2001 Jan 16; 96(1):53-9. PubMed ID: 11285475
    [Abstract] [Full Text] [Related]

  • 26. Anti-T. cruzi agents: our experience in the evaluation of more than five hundred compounds.
    Cerecetto H, González M.
    Mini Rev Med Chem; 2008 Nov 16; 8(13):1355-83. PubMed ID: 18991753
    [Abstract] [Full Text] [Related]

  • 27. TcI, TcII and TcVI Trypanosoma cruzi samples from Chagas disease patients with distinct clinical forms and critical analysis of in vitro and in vivo behavior, response to treatment and infection evolution in murine model.
    Oliveira MT, Branquinho RT, Alessio GD, Mello CGC, Nogueira-de-Paiva NC, Carneiro CM, Toledo MJO, Reis AB, Martins-Filho OAM, Lana M.
    Acta Trop; 2017 Mar 16; 167():108-120. PubMed ID: 27908747
    [Abstract] [Full Text] [Related]

  • 28. Effects of buthionine sulfoximine nifurtimox and benznidazole upon trypanothione and metallothionein proteins in Trypanosoma cruzi.
    Maya JD, Rodríguez A, Pino L, Pabón A, Ferreira J, Pavani M, Repetto Y, Morello A.
    Biol Res; 2004 Mar 16; 37(1):61-9. PubMed ID: 15174306
    [Abstract] [Full Text] [Related]

  • 29. Trypanocidal activity of 4 isopropyl salicylaldehyde and 4-isopropyl salicylic acid on Trypanosoma cruzi.
    Nogueda-Torres B, Rodríguez-Paez L, Ramírez IB, Ramírez CW.
    Rev Latinoam Microbiol; 2001 Mar 16; 43(1):1-6. PubMed ID: 17061565
    [Abstract] [Full Text] [Related]

  • 30. [Nifurtimox, a bright future for treatment of Chagas disease].
    Wolf A, Boulliat C, Coillot C, Rouault M, Gaillard K, Beranger C, Oliver M.
    Med Trop (Mars); 2011 Apr 16; 71(2):131-3. PubMed ID: 21695868
    [Abstract] [Full Text] [Related]

  • 31. Comparative studies of drug susceptibility of five strains of Trypanosoma cruzi in vivo and in vitro.
    Neal RA, van Bueren J.
    Trans R Soc Trop Med Hyg; 1988 Apr 16; 82(5):709-14. PubMed ID: 3075357
    [Abstract] [Full Text] [Related]

  • 32. Damage of Trypanosoma cruzi deoxyribonucleic acid by nitroheterocyclic drugs.
    Goijman SG, Frasch AC, Stoppani AO.
    Biochem Pharmacol; 1985 May 01; 34(9):1457-61. PubMed ID: 3888226
    [Abstract] [Full Text] [Related]

  • 33. Molecular and biological characterization of a highly pathogenic Trypanosoma cruzi strain isolated from a patient with congenital infection.
    Gulin JEN, Bisio M, Rocco DM, Altcheh J, Solana ME, García-Bournissen F.
    Exp Parasitol; 2018 Mar 01; 186():50-58. PubMed ID: 29448038
    [Abstract] [Full Text] [Related]

  • 34. Biochemical behavior of Trypanosoma cruzi strains isolated from mice submitted to specific chemotherapy.
    Marretto JP, Andrade SG.
    Rev Soc Bras Med Trop; 1994 Mar 01; 27(4):209-15. PubMed ID: 7855362
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of the trypanocidal, cytotoxic and genotoxic activity of styrylquinoline analogs.
    García P, Genes C, Molano P, Torres O, Saez J, Triana O.
    J Chemother; 2010 Jun 01; 22(3):169-74. PubMed ID: 20566421
    [Abstract] [Full Text] [Related]

  • 36. Effects of nifurtimox and benznidazole upon glutathione and trypanothione content in epimastigote, trypomastigote and amastigote forms of Trypanosoma cruzi.
    Maya JD, Repetto Y, Agosín M, Ojeda JM, Tellez R, Gaule C, Morello A.
    Mol Biochem Parasitol; 1997 May 01; 86(1):101-6. PubMed ID: 9178272
    [No Abstract] [Full Text] [Related]

  • 37. [Different effects of nifurtimox and benznidazole on the biosynthesis of DNA, RNA and proteins in Trypanosoma cruzi].
    Goijman SG, Frasch AC, Stoppani AO.
    Medicina (B Aires); 1984 May 01; 44(3):261-70. PubMed ID: 6085847
    [No Abstract] [Full Text] [Related]

  • 38. Trypanosoma cruzi: In vitro effect of aspirin with nifurtimox and benznidazole.
    López-Muñoz R, Faúndez M, Klein S, Escanilla S, Torres G, Lee-Liu D, Ferreira J, Kemmerling U, Orellana M, Morello A, Ferreira A, Maya JD.
    Exp Parasitol; 2010 Feb 01; 124(2):167-71. PubMed ID: 19735656
    [Abstract] [Full Text] [Related]

  • 39. Drug Discovery for Paediatric Chagas Disease.
    Thota S, Morel CM.
    Mini Rev Med Chem; 2018 Feb 01; 18(9):776-780. PubMed ID: 26202205
    [Abstract] [Full Text] [Related]

  • 40. [Rational concepts and the study of active molecules against various trypanosomiases].
    Périé J, de Albuquerque C, Blonski C, Chauvière G, Gefflaut T, Page P, Trinquier M, Willson M.
    Bull Soc Pathol Exot; 1994 Feb 01; 87(5):353-61. PubMed ID: 7496200
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.